SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending downwards as investors react to increased spending forecasts related to AI, drawing comparisons to the company's metaverse investments; the community is debating whether this dip represents a buying opportunity or signals deeper concerns about Meta's direction, with some citing a one-time tax charge as the primary driver, while others point to overall market weakness or algorithmic reactions.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around the iconic Rage Guy meme, emphasizing a return to OG meme culture and community-driven growth. Discussions highlight the importance of belief and shared effort, with community members expressing bullish sentiment and encouraging each other to "RAGE ON" and "work for their bags". The movement is positioned as a cultural correction against soulless memecoins.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors anticipate the company's earnings report and how effectively it's monetizing data through AI partnerships. Community members are discussing revenue estimates, daily active user growth, and the potential for a post-earnings rally or selloff. Some are also pointing to potential connections with other trending stocks and broader market factors.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific ($CORZ) is trending as shareholders prepare to vote on a proposed merger with CoreWeave ($CRWV), with many in the community expressing concerns that the deal undervalues $CORZ, particularly given its AI infrastructure potential. Some investors believe that rejecting the deal could lead to a higher valuation for $CORZ as a standalone entity or attract a better offer, while others worry about the company's future prospects without the merger.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle ($CMG) is trending due to a significant drop following a lowered sales outlook, sparking discussions about consumer spending and the company's value proposition. Community members are debating whether the dip is a buying opportunity or a sign of deeper issues with the brand, citing concerns about pricing, portion sizes, and competition in the fast-casual dining sector.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

EBS is trending due to raised FY25 EBITDA guidance, sparking optimism about the company's future profitability. The community is discussing the potential for a significant stock re-rating and a short squeeze, with some highlighting the low P/E ratio relative to the broader market. Discussions also involve potential catalysts like government appropriations and debt refinancing.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid unconfirmed rumors of a potential buyout, sparking active discussions within the investment community. The speculation surfaces as the company focuses on oncology and prepares to report earnings in November. Community members are weighing the potential deal price and strategic implications for Moderna's future.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC is trending as investors digest recent earnings and a reduced dividend, leading to a sharp price decline. The community is debating whether this presents a value opportunity or signals deeper challenges for the company, with some citing an overreaction and oversold conditions. Bullish sentiment is building around potential for a price rebound given its inclusion in the S&P 500.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as community members discuss the potential for a short squeeze, driven by high short interest and optimism around the company's pipeline. Chatter revolves around buyout speculation, comparisons to competitors, and anticipation for upcoming presentations at ObesityWeek. The stock's recent performance and market dynamics in the obesity treatment sector are also fueling the conversation.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is trending due to upcoming Phase 3 data for its DMD treatment, with investors closely watching for positive results that could lead to FDA approval; community chatter reflects both excitement and apprehension, as the data represents a pivotal moment for the company. Community members also highlight BlackRock's substantial stake in Capricor. Some traders cite the potential for a significant short squeeze based on the stock's high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?

Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?

Here's Why It's Time to Revisit Consumer Staples ETFs

Rising inflation and weakening sentiment are driving investors toward defensive consumer staple ETFs.

Analysts voiced skepticism over Target's choice of a two-decade company veteran as its next chief executive, warning that his appointment signals continuity rather than the sweeping changes the retailer needs to revive growth, particularly as tariff pressures mount.Is Michael Fiddelke, currently the chief operating officer, really an agent of change, argued DA Davidson, calling the move "catalyst lost." The research firm lowered its price target on the company's stock to $115 from $125, while maintaining its 'Buy' rating.Fiddelke, 49, will start in February next year and replace CEO Brian Cornel, who will retire. Fiddelke said on the earnings call that returning to growth would be his number one priority.Truist, which also lowered its price target while maintaining its 'Hold rating, stated that "substantial" investment changes, which Target needs to improve its long-term relevance, seem "less likely to occur under a long-time Target veteran."Jefferies lowered its price target by $5 and maintained its&nbsp;‘Buy’&nbsp;rating. Currently, 23 of the 37 analysts covering Target have a 'Hold' rating, nine rate it 'Buy' or higher, and four rate it 'strong sell,' according to Koyfin data. Their average price target is $102.68, just 4% below the last closing price.In recent years, Target has struggled to attract consumers and grow sales, losing its edge to discount retailers like Walmart and e-commerce companies. The Target brand had grown by offering fashionable items and slightly trendy everyday goods, which helped it differentiate. Now, even&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/target-faces-growth-challenges-as-staff-give-thumbs-down-to-management-efforts-report/chruFqaRdIR">employees say</a> the management is not doing enough to keep that up.A rebuke of gay Pride merchandise in 2023, as well as some Diversity, Equity, and Inclusion (DEI) policies earlier this year, have&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/target-stock-sinks-after-slashing-outlook-q1-earnings-miss/ch0edYhRbYL">hurt sales</a> and angered some investors and workers in recent quarters.The mood among retail investors, however, improved late Wednesday, especially after Target's upbeat quarterly report. In the second quarter, same-store sales fell less than feared, and overall revenue topped forecasts.On Stocktwits, the retail sentiment for Target climbed multiple notches higher in the 'extremely bullish' (91/100), with 'extremely high' message volume, as of late Wednesday.$TGT So we double beat, AND we got rid of that sh**ty DEI retard of a CEO and this goes down 10%?" a user posted. "Well all I can say is thank you to whoever sold me those shares this morning."<stembedurl>https://stocktwits.com/OnlyBuysDips/message/626008801</stembedurl><a href="https://stocktwits.com/symbol/TGT">Target shares</a> are down 27% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Customers enter and exit a Target store on November 20, 2024 in Austin, Texas. (Photo by Brandon Bell/Getty Images)

Agent For Change? Wall Street Questions Target Veteran Fiddelke's Appointment As CEO Over Doubts About Transformational Changes

Retail investors, however, took a bullish view after the big box retailer's upbeat quarterly report.

Wall Street Questions Target Veteran Fiddelke's Appointment As CEO Over Doubts About Transformational Changes

Equity

Retail investors, however, took a bullish view after the big box retailer's upbeat quarterly report.


Tough Road Ahead for U.S. Consumers? ETFs to Consider

Consumer confidence slips amid tariff fears and debt worries, boosting the case for consumer staples ETFs.

Constellation Brands (STZ) reported first-quarter results below Wall Street expectations on Wednesday. However, some positive comments on tariff headwind mitigation and an unchanged full-year outlook lifted shares.<a href="https://stocktwits.com/symbol/STZ">Constellation stock</a> gained 4.5% to $173.87, its best intraday gains in nearly three months. Shares are down 21.3% year-to-date.CEO Bill Newlands said Constellation "continued to face softer consumer demand largely driven by what we believe to be non-structural socioeconomic factors.Earlier this week, Bank of America&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bof-a-downgrades-miller-lite-brewer-molson-coors-amid-softness-in-us-beer-sales/chmZESFRReS">downgraded</a> peer Molson Coors Beverage's (TAP) shares, stating that it expects U.S. beer volumes to shrink by 4% next year, a steeper decline than its earlier prediction of a 1% decrease.Q1 revenue at Constellation, known for Corona beer and Robert Mondavi wine, dropped 6% to $2.52 billion, slightly below analysts' expectations. Earnings per share were $3.22, also below the estimate.Management stated that the company anticipates an approximately $20 million impact from aluminum tariffs for the remainder of its fiscal year, down from its earlier expectation of $30 million. Despite that, the company expects to maintain its targeted margin growth.On Stocktwits, the retail sentiment for the company shifted to 'bullish' from 'extremely bullish' the previous day.<figure class="image"><img style="aspect-ratio:580/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_03_at_10_29_59_AM_png_4106cdf670.webp" alt="Screenshot 2025-07-03 at 10.29.59 AM.png" width="580" height="61"><figcaption>STZ sentiment and message volume as of July 2 | Source: Stocktwits</figcaption></figure>A user said, "The exuberance (in the stock) seems a bit irrational," and backed it&nbsp;up by saying the company faces "declining market share, declining sales, declining profit, 25% tariff on Mexican beer, customer base being deported."<stembedurl>https://stocktwits.com/SaltyNuts/message/619760718</stembedurl>Following the results, Bank of America maintained its 'Neutral' rating on&nbsp;STZ stock&nbsp;and raised the price target by $2 to $182.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bottles of Corona beer are displayed on a shelf at a BevMo store on January 05, 2024 in San Rafael, California. (Photo by Justin Sullivan/Getty Images)

Constellation Brands Share Rise Despite Weak Earnings: Retail Sentiment Drops

The brewer of Corona beer maintained its full-year financial outlook.

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

RSPS
Invesco S&P 500 Equal Weight Consumer Staples ETF

Feed

News

Sentiment

Fundamentals

Info

Latest RSPS News

RSPSInvesco S&P 500 Equal Weight Consumer Staples ETF